Form 13-F position report

U S PHYSICALTHERAPY INC

Reported by RIVERBRIDGE PARTNERS LLC

Company profile Manager portfolio Source filing
USPH CUSIP 90337L108 Manager CIK 0001112325
Latest reported change

Reported 408,904 shares, up 6,682 (1.7%) from the prior quarter.

Reported value 22.8%; share count 1.7% vs. the prior quarter.

Added
% of reported 13F value 0.56% This manager · Q1 2023
Shares 408,904 Quarter-end amount reported
Reported value $40,035,803 Fair value at quarter end
Consecutive quarters held 26 Through Q1 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

16 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q2 2025 Reduced 0 -283,261 (-100.0%) 0 $0 2025-07-15
Q1 2025 Reduced 283,261 -26,949 (-8.7%) 0.33% $20,496,760 2025-04-21
Q4 2024 Reduced 310,210 -25,921 (-7.7%) 0.38% $27,518,773 2025-01-17
Q3 2024 Reduced 336,131 -11,668 (-3.4%) 0.38% $28,446,783 2024-10-15
Q2 2024 Reduced 347,799 -28,926 (-7.7%) 0.44% $32,143,550 2024-07-17
Q1 2024 Reduced 376,725 -10,753 (-2.8%) 0.52% $42,520,947 2024-04-26
Q4 2023 Reduced 387,478 -5,890 (-1.5%) 0.45% $36,089,685 2024-01-24
Q3 2023 Reduced 393,368 -7,052 (-1.8%) 0.49% $36,083,624 2023-10-16
Q2 2023 Reduced 400,420 -8,484 (-2.1%) 0.61% $48,606,994 2023-07-25
Q1 2023 Added 408,904 +6,682 (1.7%) 0.56% $40,035,803 2023-04-21
Q4 2022 Reduced 402,222 -4,649 (-1.1%) 0.49% $32,592,000 2023-01-11
Q3 2022 Reduced 406,871 -3,046 (-0.7%) 0.46% $30,930,000 2022-10-26
Q2 2022 Reduced 409,917 -12,441 (-2.9%) 0.72% $44,763,000 2022-07-11
Q1 2022 Added 422,358 +41,012 (10.8%) 0.47% $42,004,000 2022-04-20
Q4 2021 Added 381,346 +12,295 (3.3%) 0.36% $36,438,000 2022-01-14
Q3 2021 Reduced 369,051 -1,413 (-0.4%) 0.41% $40,817,000 2021-10-26
Five years are shown. A free account unlocks the complete reported history. Unlock full history
Institutional context

Who else reported the position

217 managers reported U S PHYSICALTHERAPY INC for Q1 2023.

Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 2,015,404 -66,095 < 0.01% $197,328,207 40 qtrs
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC Reduced 1,495,514 -36,019 0.43% $146,425,811 22 qtrs
VANGUARD GROUP INC Reduced 921,898 -678 < 0.01% $90,263,033 40 qtrs
T Rowe Price Investment Management Inc Reduced 874,570 -41,261 0.06% $85,630,000 3 qtrs
MORGAN STANLEY Added 789,978 +87,808 < 0.01% $77,346,916 40 qtrs
Copeland Capital Management LLC Added 693,280 +90,115 1.6% $67,879,000 9 qtrs
Boston Trust Walden Corp Added 548,095 +19,304 0.46% $53,663,982 32 qtrs
STATE STREET CORPORATION Added 475,403 +11,178 < 0.01% $46,750,869 40 qtrs
RIVERBRIDGE PARTNERS LLC This report Added 408,904 +6,682 0.56% $40,035,803 26 qtrs
DIMENSIONAL FUND ADVISORS LP Reduced 364,207 -18 0.01% $35,658,528 40 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2023
Filed
April 21, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
315,443
Shared
0
None
93,461

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.